[A2-Norleucine]Insulin. An Analog with Unanticipated Biological Properties

Authors:
  • YOYoshio Okada
    Yoshio Okada
  • JCJacob D. Chanley
    Jacob D. Chanley
  • GBG. Thompson Burke
    G. Thompson Burke
  • PKPanayotis G. Katsoyannis
    Panayotis G. Katsoyannis

Abstract
The simple replacement of the A2-isoleucine by norleucine in the insulin molecule gave an analog [A2-norleucine]insulin ([NleA2]-insulin) which possessed insignificant rat receptor-binding affinity and in vitro biological rat activity, 0.6 and 0.9%, respectively, compared to the natural hormone. Circular dichroic studies showed that this analog is monomeric and indicated that the helical segment A2-A8 and the .beta. strand B24-B29 have undergone conformational changes. The reduced receptor-binding affinity of [NleA2]insulin is attributed to the distortion ofthe A2-A8 helical segment which in turn may lead to the displacement of the A1, A5 and A19 residues which are putatively involved in receptor binding.

This publication has 16 references indexed in Scilit: